GMOs that are good for your health, and increasingly accessible!
The United States Food and Drug Administration (FDA) just approved two innovative therapies to treat sickle cell anemia, a genetic blood disease, the most common genetic disease in France, in patients aged 12 and over. Among them, Casgevy is the first therapy using CRISPR-Cas9, a technology allowing very precise modification of DNA. (info brief.science).
Explanations on this technology, which directly allows you to replace, add or remove a piece of DNA in a gene:
(Note to anti-vaxxers and other congenital idiots: the DNA sequence at the origin of intelligence has not yet been identified. But hold out hope, as soon as it is, you will be able to benefit from it
).